Mazindol is a tricyclic anorexigenic agent that is unrelated to and less toxic than [amphetamine], but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter. Mazindol is only approved in the United States for the treatment of Duchenne muscular dystrophy, and is not marketed or available in the United States for use in the treatment of obesity. It is grouped under the following drug class(es): Schedule IV controlled substances. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Teronac, Magrilon, Dimagrir and Terenac. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 4020.
Mazindol
| CAS No | 22232-71-9 |
|---|---|
| Molecular Formula | C16H13ClN2O |
| Molecular Weight | 284.74 g/mol |
| Synonyms | 5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mazindol is a tricyclic anorexigenic agent that is unrelated to and less toxic than [amphetamine], but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
The listed CAS number is 22232-71-9.
The listed molecular formula is C16H13ClN2O.
The listed molecular weight is 284.74 g/mol.
5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol.
The source lists Teronac, Magrilon, Dimagrir and Terenac.